Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4920524

CN(C)[C@H](Cc1ccccc1)C(=O)O.O=C(O)C(F)(F)F

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.54
MAPT P10636 1/20 0.54
CPA1 P15085 1/20 0.51
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
CYP1A2 P05177 1/20 0.47
ADAMTS5 Q9UNA0 1/20 0.46
MLYCD O95822 1/20 0.44
CES1 P23141 1/20 0.44
CTRB1 P17538 1/20 0.44
ALPI P09923 1/20 0.44
PKM P14618 1/20 0.44
PTGS1 P23219 1/20 0.44
XIAP P98170 1/20 0.44
SLC7A5 Q01650 1/20 0.44
CYP2C19 P33261 1/20 0.44
HPGD P15428 1/20 0.44
NR4A2 P43354 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL121727 0.91 MAPT (0.61) ALDH1A1MAPTCPA1MEN1KMT2A
SCHEMBL121728 0.91 MAPT (0.61) ALDH1A1MAPTCPA1MEN1KMT2A
SCHEMBL756362 0.91 MAPT (0.61) ALDH1A1MAPTCPA1MEN1KMT2A
Hydrochloric Acid SCHEMBL1082353 0.90 ALDH1A1 (0.64) ALDH1A1MAPTCPA1MEN1KMT2A
Hydrochloric Acid SCHEMBL6475636 0.90 ALDH1A1 (0.64) ALDH1A1MAPTCPA1MEN1KMT2A
Hydrochloric Acid SCHEMBL1082351 0.90 ALDH1A1 (0.64) ALDH1A1MAPTCPA1MEN1KMT2A
SCHEMBL7856007 0.84 CPA1 (0.49) ALDH1A1MAPTCPA1CYP1A2ADAMTS5
SCHEMBL7856004 0.84 CPA1 (0.49) ALDH1A1MAPTCPA1CYP1A2ADAMTS5
Trifluoroacetic Acid SCHEMBL29698941 0.82 PPARA (0.45) ALDH1A1MAPTCPA1CES1PPARG
SCHEMBL10197473 0.81 ALDH1A1 (0.68) ALDH1A1MAPTCPA1ADAMTS5PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080064676-A1 Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity ASTRAZENECA AB (SE) 2008-03-13 US disclosed
EP-1896407-A1 NOVEL 2-AZETIDINONE DERIVATIVES AND THEIR USE AS CHOLESTEROL ABSORPTION INHIBITORS FOR THE TREATMENT OF HYPERLIPIDAEMIA AstraZeneca AB (SE) 2008-03-12 EP disclosed
WO-2006137782-A1 NOVEL 2-AZETIDINONE DERIVATIVES AND THEIR USE AS CHOLESTEROL ABSORPTION INHIBITORS FOR THE TREATMENT OF HYPERLIPIDAEMIA ASTRAZENECA AB (SE) 2006-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064676-A1 Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity CYP46A1, CYP51A1, DHCR7 ALDH1A1 468/4885MAPT 2370/4885CPA1 1654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.